SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hommes, O.
Right arrow Articles by Frequin, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hommes, O.
Right arrow Articles by Frequin, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future

OR Hommes

Institute of Neurology, University Hospital Nijmegan

F Barkhof

Department of Radiology, Academic Hospital, Free University Amsterdam

PJH Jongen

Institute of Neurology, University Hospital Nijmegan

STFM Frequin

Department of Neurology, Antonius Hospital, Nieuwegein, the Netherlands

High dose intravenous methylprednisolone treatment is effective and safe in the treatment of relapses in multiple sclerosis, but the long term effects are unclear. Pharmacokinetics are almost unknown, but may be very important for the understanding of the clinical and paraclinical effects. In view of what is known now, IVMP should have a prominent place in basic and clinical MS research.

Key Words: methylprednisolone • pharmacokinetics • future

Multiple Sclerosis, Vol. 1, No. 6, 327-328 (1996)
DOI: 10.1177/135245859600100607
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement